You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 162 No. 5, May 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Adolescent Medicine
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Inflammatory Proteins and Muscle Strength in Adolescents

The AVENA Study

Jonatan R. Ruiz, PhD; Francisco B. Ortega, PhD; Julia Wärnberg, PhD; Luis A. Moreno, MD, PhD; Juan J. Carrero, PhD; Marcela Gonzalez-Gross, PhD; Ascension Marcos, PhD; Angel Gutierrez, MD, PhD; Michael Sjöström, MD, PhD

Arch Pediatr Adolesc Med. 2008;162(5):462-468.

Objectives  To examine the associations between inflammatory proteins and muscle strength and to determine whether this association varies between overweight and nonoverweight adolescents.

Design  Cross-sectional study.

Participants  A total of 416 Spanish adolescents (230 boys and 186 girls) aged 13 to 181/2 years.

Main Exposures  Muscle strength score was computed as the mean of the handgrip and standing broad jump standardized values. The adolescents were categorized as overweight (including obese) or nonoverweight according to body mass index. Body fat and fat-free mass were derived from skinfold thickness.

Outcome Measures  C-reactive protein, complement factors C3 and C4, ceruloplasmin, and prealbumin levels.

Results  The results of the regression analysis showed that C-reactive protein, C3, and ceruloplasmin were negatively associated with muscle strength after controlling for sex, age, pubertal status, weight, height, socioeconomic status, and cardiorespiratory fitness. Moreover, C-reactive protein and prealbumin levels were associated with muscle strength in overweight adolescents after controlling for potential confounders, including body fat and fat-free mass.

Conclusions  Low-grade inflammation is negatively associated with muscle strength in adolescents. The patterns of these associations seem more relevant in overweight adolescents, suggesting that having high levels of muscle strength may counteract the negative consequences ascribed to body fat.


Author Affiliations: Unit for Preventive Nutrition, Department of Biosciences and Nutrition at Novum (Drs Ruiz, Ortega, Wärnberg, and Sjöström) and Division of Renal Medicine and Baxter Novum, Department of Clinical Science (Dr Carrero), Karolinska Institutet, Huddinge, Sweden; Department of Physiology, School of Medicine, University of Granada, Granada, Spain (Drs Ruiz, Ortega, and Gutierrez); Immunonutrition Research Group, Department of Metabolism and Nutrition, Consejo Superior de Investigaciones Científicas, Madrid, Spain (Drs Wärnberg and Marcos); Escuela Universitaria Health Sciences, University of Zaragoza, Zaragoza, Spain (Dr Moreno); and School of Sport Sciences, Universidad Politécnica de Madrid, Madrid, Spain (Dr Gonzalez-Gross).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Acylation stimulating protein but not complement C3 associates with metabolic syndrome components in Chinese children and adolescents
Wamba et al.
Eur J Endocrinol 2008;159:781-790.
ABSTRACT | FULL TEXT  

Clinical Measures of Physical Fitness Predict Insulin Resistance in People at Risk for Diabetes
Chen et al.
ptjournal 2008;88:1355-1364.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.